Aquestive Therapeutics Inc
NASDAQ:AQST
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2
6.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
AQST Price Targets Summary
Aquestive Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AQST is 11.05 USD with a low forecast of 5.56 USD and a high forecast of 17.85 USD.
AQST Last Price Targets
Aquestive Therapeutics Inc
The latest public price target was made on Nov 6, 2024 by
Thomas Flaten
from
Loop Capital Markets
,
who expects
AQST
stock to
rise by 179%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Thomas Flaten
Loop Capital Markets
|
10
USD
Upside 179% |
1 month ago
Nov 6, 2024
|
Aquestive Therapeutics (AQST) PT Raised to $10 at Lake Street Capital Markets
StreetInsider
|
|
Thomas Flaten
Loop Capital Markets
|
7
USD
Upside 95% |
5 months ago
Jun 25, 2024
|
Aquestive Therapeutics (AQST) PT Lowered to $7 at Lake Street Capital Markets
StreetInsider
|
David Amsellem
Piper Sandler
|
10
USD
Upside 179% |
8 months ago
Apr 11, 2024
|
Piper Sandler Starts Aquestive Therapeutics (AQST) at Overweight, 'he risk/reward profile associated with AQST shares is attractive'
StreetInsider
|
|
Raghuram Selvaraju
H.C. Wainwright
|
9
USD
Upside 151% |
9 months ago
Mar 18, 2024
|
Aquestive Therapeutics (AQST) PT Raised to $9 at H.C. Wainwright
StreetInsider
|
Francois Brisebois
Oppenheimer
|
12
USD
Upside 234% |
9 months ago
Mar 15, 2024
|
Aquestive Therapeutics (AQST) PT Raised to $12 at Oppenheimer
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AQST's stock price target?
Price Target
11.05
USD
According to Wall Street analysts, the average 1-year price target for AQST is 11.05 USD with a low forecast of 5.56 USD and a high forecast of 17.85 USD.
What is Aquestive Therapeutics Inc's Revenue forecast?
Projected CAGR
29%
For the last 6 years the compound annual growth rate for Aquestive Therapeutics Inc's revenue is -5%. The projected CAGR for the next 4 years is 29%.
You don't have any saved screeners yet
